Clinical Trial

Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How?

Recruiting
View on ClinicalTrials.gov →
Summary
This research project will assess how two treatments for irritable bowel syndrome (one dietary and one behavioral) work and for whom. This will be done by assessing moderators (what treatment works for who and in what context) and mediators (how treatment works). Investigators will also assess how the diet and behavioral treatments affect IBS symptoms during treatment. Participants will be randomized to either: i. A FODMAP diet online program that focuses on modifying the consumption of foods high or moderate in fermentable carbohydrates (FODMAPS) to manage IBS symptoms. or, ii. An Exposure-based Cognitive Behavioral Therapy (E-CBT) online program for IBS that focuses on changing symptom-related behaviors which are known to worsen IBS symptoms.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-15; most recent amendment 2026-04-29.
Status change: Not Yet Recruiting → Recruiting 2025-07-07
Trial Details
NCT Number NCT06940596
Lead Sponsor University of Melbourne
Collaborators: Monash University
Conditions Irritable Bowel Syndrome (IBS), Intestinal Diseases, Gastrointestinal Disease
Enrollment 235 participants
Start Date 2025-05-22
Primary Completion 2027-10 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-06